Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +4.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (617)

clinicaltrialsPublishedShowing 101–150 of 229 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07591649	Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT	recruiting	Phase 1 / Phase 2	18	Masonic Cancer Center, University of MinnesotaOTHER	1	May 19, 2026	clinicaltrials
NCT05133882	A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML	recruiting	Phase 1 / Phase 2	133	Sunshine Lake Pharma Co., Ltd.INDUSTRY	1	May 15, 2026	clinicaltrials